Literature DB >> 9861035

A nucleated assembly mechanism of Alzheimer paired helical filaments.

P Friedhoff1, M von Bergen, E M Mandelkow, P Davies, E Mandelkow.   

Abstract

Alzheimer's disease is characterized by two types of fibrous aggregates in the affected brains, the amyloid fibers (consisting of the Abeta-peptide, generating the amyloid plaques), and paired helical filaments (PHFs; made up of tau protein, forming the neurofibrillary tangles). Hence, tau protein, a highly soluble protein that normally stabilizes microtubules, becomes aggregated into insoluble fibers that obstruct the cytoplasm of neurons and cause a loss of microtubule stability. We have developed recently a rapid assay for monitoring PHF assembly and show here that PHFs arise from a nucleated assembly mechanism. The PHF nucleus comprises about 8-14 tau monomers. A prerequisite for nucleation is the dimerization of tau because tau dimers act as effective building blocks. PHF assembly can be seeded by preformed filaments (made either in vitro or isolated from Alzheimer brain tissue). These results suggest that dimerization and nucleation are the rate-limiting steps for PHF formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861035      PMCID: PMC28109          DOI: 10.1073/pnas.95.26.15712

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Kinetics of the cooperative association of actin to actin filaments.

Authors:  A Wegner; J Engel
Journal:  Biophys Chem       Date:  1975-07       Impact factor: 2.352

Review 2.  Amyloid beta-protein and the genetics of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

3.  Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction.

Authors:  M Pérez; J M Valpuesta; M Medina; E Montejo de Garcini; J Avila
Journal:  J Neurochem       Date:  1996-09       Impact factor: 5.372

4.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Authors:  O Schweers; E Schönbrunn-Hanebeck; A Marx; E Mandelkow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

Review 5.  Oxidative damage and mitochondrial decay in aging.

Authors:  M K Shigenaga; T M Hagen; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

7.  Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

Authors:  P E Fraser; D R McLachlan; W K Surewicz; C A Mizzen; A D Snow; J T Nguyen; D A Kirschner
Journal:  J Mol Biol       Date:  1994-11-18       Impact factor: 5.469

8.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

Authors:  M Goedert; R Jakes; M G Spillantini; M Hasegawa; M J Smith; R A Crowther
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

Review 9.  The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.

Authors:  R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1996-10       Impact factor: 3.685

10.  Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments.

Authors:  O Schweers; E M Mandelkow; J Biernat; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more
  89 in total

1.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.

Authors:  M von Bergen; P Friedhoff; J Biernat; J Heberle; E M Mandelkow; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Multistep nucleus formation and a separate subunit contribution of the amyloidgenesis of heat-denatured monellin.

Authors:  T Konno
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

3.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

4.  Template-assisted filament growth by parallel stacking of tau.

Authors:  Martin Margittai; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  Characterization of tau fibrillization in vitro.

Authors:  Shaohua Xu; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

6.  A statistical-mechanical theory of fibril formation in dilute protein solutions.

Authors:  Jeroen van Gestel; Simon W de Leeuw
Journal:  Biophys J       Date:  2006-05-01       Impact factor: 4.033

Review 7.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

8.  Pseudophosphorylation of tau protein directly modulates its aggregation kinetics.

Authors:  Edward Chang; Sohee Kim; Kelsey N Schafer; Jeff Kuret
Journal:  Biochim Biophys Acta       Date:  2010-10-23

9.  Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.

Authors:  Erin E Congdon; Sohee Kim; Jonathan Bonchak; Tanakorn Songrug; Anastasios Matzavinos; Jeff Kuret
Journal:  J Biol Chem       Date:  2008-03-21       Impact factor: 5.157

Review 10.  Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.

Authors:  Xuling Li; Simon James; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-09-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.